Markus Glaffig

A Fully Synthetic Four‐Component Antitumor Vaccine Consisting of a Mucin Glycopeptide Antigen Combined with Three Different T‐Helper‐Cell Epitopes

Björn Palitzsch, Sebastian Hartmann, Natascha Stergiou et al. · Angewandte Chemie International Edition · 2014 · 59 citations

Medicine, Immunology, Oncology +17

A Synthetic MUC1 Anticancer Vaccine Containing Mannose Ligands for Targeting Macrophages and Dendritic Cells

Markus Glaffig, Natascha Stergiou, Sebastian Hartmann et al. · ChemMedChem · 2017 · 56 citations

Medicine, Immunology, Oncology +17

CpG‐Loaded Multifunctional Cationic Nanohydrogel Particles as Self‐Adjuvanting Glycopeptide Antitumor Vaccines

Sebastian Hartmann, Lutz Nuhn, Björn Palitzsch et al. · Advanced Healthcare Materials · 2014 · 54 citations

Pharmacy, Immunology, Pharmaceutics +17

A Fully Synthetic Glycopeptide Antitumor Vaccine Based on Multiple Antigen Presentation on a Hyperbranched Polymer

Markus Glaffig, Björn Palitzsch, Sebastian Hartmann et al. · Chemistry - A European Journal · 2014 · 52 citations

Medicine, Immunology, Oncology +17

Immunization with a Synthetic Human MUC1 Glycopeptide Vaccine against Tumor‐Associated MUC1 Breaks Tolerance in Human MUC1 Transgenic Mice

Natascha Stergiou, Markus Glaffig, Helmut Jonuleit et al. · ChemMedChem · 2017 · 33 citations

Medicine, Immunology, Oncology +17